Tag Archives: QuantuMDx Group

QuantuMDx explored licensing opportunities for its rapid DNA extraction kit Q-PREP at BIO in Philadelphia, which took place in mid-June. Q-PREP is a next-generation DNA extraction technology set to dramatically shorten and simplify the molecular workflow for polymerase chain reaction, sequencing, and other molecular processes. The technology is presently being deployed in next-generation spin columns.

January 2015—FIND, a Geneva-based nonprofit organization, and QuantuMDx Group, a British medical device developer, are joining forces to develop a solution for the combined detection of and drug susceptibility determination for the causative agent for tuberculosis.